Cholangiocarcinoma Awareness Month – Do you know the signs and symptoms of bile duct cancer?


Cholangiocarcinoma Awareness Month - Bile Duct Cancer Awareness

Cholangiocarcinoma Awareness Month – Bile Duct Cancer Awareness

This month as you can see is Cholangiocarcinoma Awareness Month. Or translated from medicalese it is Bile Duct Cancer Awareness Month.

Bile duct cancer is considered a rare form of cancer with only 1,000 people being diagnosed in the UK each year. It has been suggested that generally only 10-20 per million will develop the condition each year.

As our contribution to raising awareness of Cholangiocarcinoma we thought we would share some of the signs and symptoms that a person may have bile duct cancer.

It should be noted that symptoms only show themselves when the cancer is more advance. This is often when the bile duct is blocked.

The main signs and symptoms include

a) Jaundice
b) Itchy skin
c) Weight loss which is unexpected
d) Light colored or greasy poos
e) Belly pain
f) Dark colored urine.

If you have these symptoms it is important you contact your doctor as soon as possible!


World Cancer Day 2015 – check out this great way to show your support. #KissCancerGoodbye


World Cancer Day 2015

World Cancer Day 2015

This Wednesday 4th Feb sees one of the most important days in the medical awareness diary. The day in question is World Cancer Day.

This year social media is playing a big part in help raise awareness. One idea is to use the hashtag #KissCancerGoodbye and share a picture of you kissing a friend, family member, patient or pet. If you would share them on Twitter, Facebook or any other social media you use.

World Cancer Day have also produced a page cover for Facebook users. You can see it above. Please download and place it on your Facebook page even for just a few hours.

You might also be interested in joining our cancer community called CancerTalk. This is a space where all those in the cancer community can share experiences and provide support.

Thanks very much in advance.


Noncommunicable diseases prematurely take 16 million lives annually


Lupus Awareness Month

Lupus Awareness Month

Urgent government action is needed to meet global targets to reduce the burden of noncommunicable diseases (NCDs), and prevent the annual toll of 16 million people dying prematurely—before the age of 70 – from heart and lung diseases, stroke, cancer and diabetes, according to a new World Health Organization report.

“The global community has the chance to change the course of the NCD epidemic,” says WHO Director-General Dr Margaret Chan, who today launched the Global status report on noncommunicable diseases 2014. “By investing just US$1-3 dollars per person per year, countries can dramatically reduce illness and death from NCDs. In 2015, every country needs to set national targets and implement cost-effective actions. If they do not, millions of lives will continue to be lost too soon.”

The report states that most premature NCD deaths are preventable. Of the 38 million lives lost to NCDs in 2012, 16 million or 42% were premature and avoidable – up from 14.6 million in 2000.


Nearly five years into the global effort to reduce premature deaths from NCDs by 25% by 2025, the report provides a fresh perspective on key lessons learned.

Premature NCD deaths can be significantly reduced through government policies reducing tobacco use, harmful use of alcohol, unhealthy diets and physical inactivity, and delivering universal health care. For example, in Brazil the NCD mortality rate is dropping 1.8% per year due in part to the expansion of primary health care.

But the report calls for more action to be taken to curb the epidemic, particularly in low- and middle-income countries, where deaths due to NCDs are overtaking those from infectious diseases. Almost three quarters of all NCD deaths (28 million), and 82% of the 16 million premature deaths, occur in low- and middle-income countries.

“Best buys” to reduce the burden

The WHO report provides the baseline for monitoring implementation of the Global action plan for NCDs 2013-2020, aimed at reducing the number of premature deaths from NCDs by 25% by 2025. Outlined in the action plan are nine voluntary global targets that address key NCD risk factors including tobacco use, salt intake, physical inactivity, high blood pressure and harmful use of alcohol.

“Our world possesses the knowledge and resources to achieve the nine global NCD targets by 2025,” says Dr Oleg Chestnov, WHO’s Assistant Director-General for Noncommunicable Diseases and Mental Health. “Falling short of the targets would be unacceptable. If we miss this opportunity to set national targets in 2015 and work towards attaining our promises in 2025, we will have failed to address one of the major challenges for development in the 21st century.”

The report provides “best buy” or cost-effective, high-impact interventions recommended by WHO, including banning all forms of tobacco advertising, replacing trans fats with polyunsaturated fats, restricting or banning alcohol advertising, preventing heart attacks and strokes, promoting

breastfeeding, implementing public awareness programmes on diet and physical activity, and preventing cervical cancer through screening. Many countries have already had success in implementing these interventions to meet global targets.

Examples of regional and country “best buy” successes listed in the report:
• Turkey was the first country to implement all the “best-buy” measures for tobacco reduction. In 2012, the country increased the size of health-warning labels to cover 65% of the total surface area of each tobacco product. Tobacco taxes now make up 80% of the total retail price, and there is currently a total ban on tobacco advertising, promotion and sponsorship nationwide. As a result, the country saw a 13.4% relative decline in smoking rates from 2008 to 2012.
• Hungary passed a law to tax food and drink components with a high risk for health, such as sugar, salt and caffeine. A year later, 40% of manufacturers changed their product formula to reduce the taxable ingredients, sales decreased 27% and people consumed 25-35% fewer products.
• Argentina, Brazil, Chile, Canada, Mexico and the USA have promoted salt reduction in packaged foods and bread. Argentina has already achieved a 25% reduction in the salt content of bread.

Working on the ground in more than 150 countries, WHO is helping develop and share “best buy” solutions so that they can be implemented more widely. WHO is also helping countries understand the dimensions that influence NCDs outside the health sector, including public policies in agriculture, education, food production, trade, taxation and urban development.

Meeting global targets

Though some countries are making progress towards the global NCD targets, the majority are off course to meet the 2025 targets. While 167 countries have operational NCD units in the ministry of health, progress on other indicators has been slow, especially in low- and middle-income countries.

As of December 2013[1] only:
• 70 countries had at least one operational national NCD plan in line with the Global NCD action plan
• 56 countries had a plan to reduce physical inactivity
• 60 countries had national plans to reduce unhealthy diets
• 69 countries had a plan to reduce the burden of tobacco use
• 66 countries had a plan to reduce the harmful use of alcohol
• 42 countries had monitoring systems to report on the nine global targets
NCDs impede efforts to alleviate poverty and threaten the achievement of international development goals. When people fall sick and die in the prime of their lives, productivity suffers. And the cost of treating diseases can be devastating – both to the individual and to the country’s health system.

From 2011-2025, cumulative economic losses due to NCDs under a “business as usual” scenario in low- and middle-income countries is estimated at US$ 7 trillion. WHO estimates the cost of reducing the global NCD burden is US$ 11.2 billion a year: an annual investment of US$ 1-3 per capita.

High rates of death and disease, particularly in low- and middle-income countries, are a reflection of inadequate investment in cost-effective NCD interventions. WHO recommends all countries move from commitment to action, by setting national targets and implementing the “best buy” interventions starting in 2015.

Comprehensive cervical cancer control: a guide to essential practice – a New WHO guide to prevent and control cervical cancer


Comprehensive cervical cancer control: a guide to essential practice

Comprehensive cervical cancer control: a guide to essential practice

New guidance from the World Health Organization aims to help countries better prevent and control cervical cancer. The disease is one of the world’s deadliest – but most easily preventable – forms of cancer for women, responsible for more than 270 000 deaths annually, 85% of which occur in developing countries.

The new Comprehensive cervical cancer control: a guide to essential practice was launched at the World Cancer Leaders’ Summit in Melbourne, Australia today.

The main elements in the new guidance are:

• Vaccinate 9 to 13-year-old girls with two doses of HPV vaccine to prevent infection with the Human papillomavirus (HPV), the virus responsible for most cases of cervical cancer. The reduced, 2-dose schedule has been shown to be as effective as the current 3-dose schedule. The change will make it easier to administer the vaccine. In addition, it reduces the cost, which is particularly important for low- and middle-income countries where national health budgets are constrained but where the need for HPV vaccine is the greatest. Today, girls in more than 55 countries are protected by routine administration of HPV vaccine. Encouragingly, a growing number of low- and middle-income countries are introducing HPV vaccine in the routine schedule, with support from the GAVI Alliance.


• Use HPV tests to screen women for cervical cancer prevention. With HPV testing, the frequency of screening will decrease. Once a woman has been screened negative, she should not be rescreened for at least five years, but should be rescreened within 10. This represents a major cost saving for health systems, in comparison with other types of tests.
• Communicate more widely. Instead of focusing mostly on encouraging the screening of women aged over 29, the guide recommends communicating with a wider audience: adolescents, parents, educators, leaders and people working at all levels of the health system, to reach women throughout their lives.

Dr Nathalie Broutet, a leading WHO expert on cervical cancer prevention and control, says: “WHO’s updated cervical cancer guidance can be the difference between life and death for girls and women worldwide. There are no magic bullets, but the combination of more effective and affordable tools to prevent and treat cervical cancer will help release the strain on stretched health budgets, especially in low-income countries, and contribute drastically to the elimination of cervical cancer.”

An estimated one million-plus women worldwide are currently living with cervical cancer. Many have no access to health services for prevention, curative treatment or palliative care.

Cervical cancer rates have fallen in much of the developed world during the past 30 years, largely due to screening and treatment programs. During the same time, however, rates in most developing countries have risen or remain unchanged, often due to limited access to health services, lack of awareness and absence of screening and treatment programmes. Rural and poorer women living in developed countries are at increased risk of invasive cervical cancer.

The new guidance highlights the importance of addressing gender discrimination and other inequities in relation to a range of other social factors (such as wealth, class, education, religion and ethnicity), in the design of health policies and programmes.

“Unless we address gender inequality and ensure women’s right to health, the number of women dying from cervical cancer will continue to rise,” says Dr Marleen Temmerman, Director of WHO’s Department of Reproductive Health and Research.

The new WHO guidance provides a comprehensive cervical cancer control and prevention approach for governments and healthcare providers. Also known as the “Pink Book,” it underlines recent developments in technology and strategy for improving women’s access to health services to prevent and control cervical cancer.

The guidance identifies key opportunities and ages throughout a woman’s life when cervical control and prevention can be put into action, especially for:
• Primary prevention: human papillomavirus (HPV) vaccination targets girls aged 9 to 13 years, aiming to reach them before they become sexually active.
• Secondary prevention: access to technology for women over 30 years of age, such as VIA (visual inspection of the cervix with acetic acid) or HPV testing for screening, followed by treatment of detected precancerous lesions, which may develop into cervical cancer.
• Tertiary prevention: access to cancer treatment and management for women of any age, including surgery, chemotherapy and radiotherapy.
• When curative treatment is no longer an option, access to palliative care is crucial.
A variety of health services and programmes are needed to implement the different elements of these recommendations. The guidance underlines the importance of collaboration between sectors, between health programmes, and between professionals working at all levels of the health service, for the success of cervical cancer prevention.

The guidelines also show how cervical prevention and control can be integrated into existing health care delivery systems, including for family planning, postpartum care and HIV/AIDS. The delivery of vaccinations to adolescents for example, opens the door to reaching them with additional health information, sexual education and advice about healthy life styles.

A global opportunity to improve women’s health: Implementing cervical cancer prevention and control programmes supports the UN Secretary-General’s 2010 Global Strategy for Women’s and Children’s Health. Cervical cancer was identified in the 2011 Political Declaration of the High-level Meeting of the UN General Assembly on the Prevention and Control of Noncommunicable Diseases.

The 2013 World Health Assembly identified cervical cancer as among the priority interventions in the action plan for the prevention and control of NCDs 2013-2020, which was agreed by Member States, committing them to including cervical cancer and other NCD interventions in national health plans.

National Stomach Cancer Awareness Month – Please share to show your support!


National Stomach Cancer Awareness Month

National Stomach Cancer Awareness Month

I know it is getting to the end of the month but, as they say, better late than never. November is National Stomach Cancer Awareness Month

Indeed a close friend from university died of stomach cancer so it is close to my heart.

Stomach cancer is the second leading cause of cancer death worldwide, with one million new cases
diagnosed each year and more than 800,000 deaths annually. Stomach cancer currently receives the
least amount of federal funding per cancer death in the United States.

So if you could share the image above that would be great.

“STOMACH CANCER AWARENESS MONTH® is a registered trademark of No Stomach For Cancer, Inc. and is used here under license. No Stomach For Cancer, Inc. is not a sponsor of PatientTalk.Org.”

About No Stomach For Cancer: Founded in 2009, No Stomach For Cancer, Inc. is a 501(c)(3) nonprofit
organization dedicated to raising awareness about stomach cancer. The organization’s mission is to
support research and unite the caring power of people worldwide affected by stomach cancer.
Headquartered in Wisconsin and serving families across the globe, No Stomach For Cancer is a worldwide leader in raising awareness and advancing education. For more information, please visit
www.nostomachforcancer.org.